Yuze Shi
Hefei, 230022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
GSTK1 suppresses HCC aggravation via L-carnitine metabolism by PGAM5/DRP1 complex-mediated mitochondrial quality control.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 30, 2025
Decreased LONP1 expression exacerbates MASH-induced liver fibrosis via elevated orotic acid levels.
Journal: Journal of hepatology
Published: January 17, 2025
Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma.
Journal: Journal of hepatology
Published: December 20, 2024
MARCO+ macrophages drive immunosuppressive remodeling and metastasis in chemotherapy-associated steatohepatitis.
Journal: Journal of hepatology
Published: November 11, 2024
SEC24C suppresses the propagation and chemoresistance of hepatocellular carcinoma by promoting unfolded protein response-related apoptosis.
Journal: Bioscience trends
Published: July 31, 2024
DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 17, 2024
NR4A1 mediates NK-cell dysfunction in hepatocellular carcinoma via the IFN-γ/p-STAT1/IRF1 pathway.
Journal: Immunology
Published: September 01, 2022
Erratum: PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum.
Journal: Theranostics
Published: June 06, 2022
Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier-Free Nanoassembly of Fluorinated Prodrug and siRNA.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 02, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026